RE: Has Avacta missed the boat, globally now?29 Sep 2020 10:05
Said this months ago, aside from the most innovative and cost-effective solution in the market, AVCT's design is still just that, a design! NCYT in retrospect, (in which i'm still not invested), is monetising and making the most of this situation!
AVCT is taking way too long whether it be the third party or themselves.. In this market as volatile as it is in the pharma sector.. too long!